Articles by Joe Tenebruso

Technology

Why Guardant Health Stock Surged Today

Shares of Guardant Health (GH +28.17%) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines. Doing well by doing good Guardant's third-quarter revenue soared by 39% year over year to $265.2 million. The gains were broad based. Revenue in the healthcare company's biopharma division jumped 18% to $54.7 million. Sales in its oncology segment leaped 31% to $184.4 million, driven by a roughly 40% increase in oncology tests to 74,000. And revenue in Guardant's promising screening business grew 24-fold to $24.1 million, as Shield screening tests rose to 24,000. Guardant's adjusted net loss, in turn, narrowed to $48.3 million from $55 million in 2024's Q3. The Guardant360 liquid biopsy test utilizes advanced genomic technology to help doctors identify suitable treatment options for patients with cancer. It can be used to gather actionable information for people with solid tumors in the lungs, breast, colon, and prostate. Additionally, Guardant's Shield blood test offers people a relatively easy way to screen for early signs of colon cancer compared to colonoscopies and stool-based testing. These potentially life-saving benefits have enabled Guardant to form partnerships with major clinical laboratories, such as Quest Diagnostics, and patient advocacy organizations, including the American Cancer Society. These collaborations are helping to fuel Guardant's growth. "We made incredible progress in screening in the third quarter," Co-CEO Helmy Eltoukhy said. "It has been very rewarding to see Shield take off and hear story after story of patients positively impacted by this pioneering test." A long runway for growth These strong results prompted Guardant to boost its full-year sales outlook. Management now sees revenue rising by 31% to $965 million to $970 million in 2025.

Technology

Why eBay Stock Sank Today

Shares of eBay (EBAY 14.95%) declined on Thursday after the online marketplace operator's profit forecast fell short of investors' expectations. As of 1:55 p.m. ET, eBay's stock price was down more than 14%. Solid sales and cash flow growth eBay's third-quarter revenue rose by 9% year over year to $2.8 billion. The e-commerce company's gross merchandise volume (GMV) -- the total value of all merchandise sold on its marketplaces -- increased by 10% to $20.1 billion. eBay earns revenue from its GMV from the fees it charges sellers. eBay is integrating artificial intelligence (AI) features into its platform to facilitate transactions between buyers and sellers. The company recently unveiled a new AI-powered messaging tool and other tech upgrades to help sellers grow their sales and profits. "We're transforming the eBay experience through AI built on 30 years of unique insights, while enhancing trusted programs in shipping, live commerce, and circular fashion," CEO Jamie Iannone said in a press release. Moreover, eBay's asset-light business model remains highly profitable. The marketplace provider produced $803 million in free cash flow from continuing operations during the third quarter. That enabled eBay to return $757 million to shareholders via dividends and stock buybacks. Tariffs could slow eBay's growth Investors, however, appeared to focus more on eBay's business outlook. Management guided for adjusted earnings per share of $1.31 to $1.36 in the fourth quarter. That was below analysts' estimates of $1.39. During eBay's earnings call, CFO Peggy Alford said the suspension of the de minimis exemption for imports under $800 for tariffs in late August began to negatively impact transaction volumes in September.